"" Apollomics Inc. (NASDAQ:APLM) CFO Peter Lin has invested $400,005 in the company’s Class A ordinary shares, according to a recent private placement transaction. The acquisition was made on August 14, 2026, when Mr. Lin purchased 26,667 Class A ordinary shares at a price of $15.0 per share.
The shares have since climbed to $23.55, reflecting a remarkable 313% return over the past year. Despite this growth, the company remains unprofitable over the last twelve months, with revenue growth of 776%.
Following this transaction, Mr. Lin directly holds 48,979 Class A ordinary shares in Apollomics Inc.
Background on Apollomics Inc.
Apollomics Inc. is a biotechnology company focused on developing innovative treatments for various diseases. The company has been working to expand its product pipeline and increase its revenue streams.
Recent Developments
The recent private placement transaction has been met with interest from investors, who are looking to capitalize on the company’s growth potential. However, the company’s unprofitable status over the past year remains a concern for investors.
Conclusion
The investment by Apollomics Inc.’s CFO, Peter Lin, is a significant development in the company’s history. As the company continues to grow and expand its product pipeline, it will be important to monitor its progress and assess its potential for future growth.
- defi-news
- regulation
- peter-lin
- class-a-ordinary-shares
- private-placement-transaction
- biotechnology
- nasdaq-aplm
- unprofitable
- revenue-growth